Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Int J Gynecol Cancer. 2016 May;26(4):785–789. doi: 10.1097/IGC.0000000000000656

Table 2. Surgical and pathologic findings.

Bartholin's Gland Carcinoma (n=33) Non-Bartholin's Gland Carcinoma (n=396) p-value
N (%) N (%)
Lesion Size (mm) 0.718
N 21 250
Mean (SD) 38.5 (19.7) 40.1 (28.0)
Median 40 30.5
Range 4 – 70 1.5 – 200
Lesion Focality 0.316
Unifocal 29 (87.9) 302 (76.3)
Multifocal 1 (3.0) 46 (11.6)
Unknown 3 (9.1) 48 (12.1)
Histologic Type 0.169
Squamous 375 (94.7)
Adenocarcinoma 29 (87.9) 14 (3.5)
Other 0 (0) 7 (1.8)
FIGO Stage 0.037
I 8 (34.3) 177 (44.7)
II 4 (12.1) 60 (15.2)
III 16(48.5) 109 (27.5)
IV 4 (12.1) 33 (8.3)
Unknown 1 (3.0) 17 (4.3)
LVSI 0.351
No 6 (18.2) 143 (36.1)
Yes 6 (18.2) 74 (18.7)
Unknown 21 (63.6) 179 (45.2)
Tumor Invasion (mm) 0.752
N 17 322
Mean (SD) 5.4 (5.1) 4.8 (4.7)
Median 3.5 3.3
Range 1 – 18 0.1 – 31
Positive Lymph Nodes 0.091
No 11 (33.3) 142 (35.9)
Yes 14 (42.4) 88 (22.2)
Not Performed/Unknown 8 (24.2) 166 (42.0)